Edition:
United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

67.12USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$67.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,264,517
52-wk High
$88.16
52-wk Low
$64.25

Lechleiter, John 

Dr. John C. Lechleiter, Ph.D. is no longer Chairman of the Board of Eli Lilly And Co., effective May 31, 2017. He resigned as President, Chief Executive Officer effective December 31, 2016. A Ph.D. chemist by training, Dr. Lechleiter has over 37 years of experience with the company in a variety of roles of increasing responsibility in research and development, pharmaceutical operations, and corporate administration. As a result, he has a sound understanding of pharmaceutical research and development, sales and marketing, and manufacturing.

Basic Compensation

Total Annual Compensation, USD 5,122,500
Restricted Stock Awards, USD 11,350,000
Long-Term Incentive Plans, USD --
All Other, USD 90,000
Fiscal Year Total, USD 16,562,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 140,964 2,864,830.00
Name Fiscal Year Total

John Lechleiter

16,562,500

Derica Rice

6,935,410

Maria Crowe

--

Jan Lundberg

6,778,350

Melissa Barnes

--

Michael Harrington

4,780,500
As Of  30 Dec 2015